Key legislators
Who's moving healthcare in Michigan
Showing 4 of 4
bills
All healthcare bills
SB 978 repeals the requirement that health insurers in Michigan provide emergency refills of prescription medications for up to a 30-day supply. This change directly affects insurance companies and their policyholders by removing the obligation to cover such emergency supplies under specific circumstances. The bill eliminates Section 3406w of the state's insurance code, which previously mandated these emergency coverage provisions. Consequently, insurers will no longer be required to grant these specific emergency refill exceptions, leaving the existing formulary and exception processes in Sections 3406o as the primary framework for drug coverage.
SB 398 modifies requirements for substance use disorder treatment programs in Michigan and prohibits state agencies from creating new rules about these services. It directly affects treatment providers and the state health department (DHHS) by changing existing standards for program operations and blocking future rulemaking on specific service requirements. Key provisions include updating program eligibility rules under MCL 333.6230 and banning the development of new rules under MCL 333.6234. The bill aims to streamline program standards while preventing additional regulatory burdens on treatment providers.
Senate Bill 136 primarily eliminates the requirement for healthcare providers to notify patients about dense breast tissue after mammography. This change directly impacts patients undergoing mammograms and the medical facilities that perform these screenings in Michigan. The bill also enacts broader amendments concerning the use of radiation machines for mammography procedures. These modifications are made by amending and repealing specific sections within the existing Public Health Code.
SB 405 amends Michigan's "Administration of Opioid Antagonists Act" by revising the definition of "governmental agency" to explicitly exclude school district boards, public school academies, and licensed healthcare providers (under Public Health Code Part 209). This change means these entities will no longer be subject to the act's requirements regarding opioid antagonist access and training. The bill directly affects school districts, public school academies, and licensed healthcare facilities by removing them from the scope of the law. The amendment clarifies which organizations must comply with the act's provisions, focusing on state and local government entities rather than schools or healthcare providers. This is a technical definitional update with no new requirements or funding changes.